Detalles de la búsqueda
1.
Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma.
In Vivo
; 36(3): 1168-1177, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35478117
2.
The relationship between P16INK4A and TP53 promoter methylation and the risk and prognosis in patients with oesophageal cancer in Thailand.
Sci Rep
; 12(1): 10337, 2022 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35725923
3.
Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
Pathol Res Pract
; 215(7): 152451, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31126817
4.
Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
Clin Epigenetics
; 11(1): 39, 2019 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30832707
5.
Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets.
iScience
; 21: 624-637, 2019 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31731200
Resultados
1 -
5
de 5
1
Próxima >
>>